The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

BMC Pulmonary Medicine

Volumn 4, Issue , 2004, Pages

  Bouros, Demosthenes ^a   Alexandrakis, Michael G ^b   Antoniou, Katerina M ^b   Agouridakis, Panagiotis ^c   Pneumatikos, Ioannis ^a   Anevlavis, Stavros ^a   Pataka, Athanasia ^a   Patlakas, George ^a   Karkavitsas, Nikolaos ^b   Kyriakou, Despina ^d  

^a UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c Rethymnon General Hospital   (Greece)

^d GENERAL HOSPITAL OF LARISSA   (Greece)

Author keywords

ARDS; Bronchoalveolar lavage; Cytokines; Outcome

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OXYGEN TENSION; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM;

EID: 13144304345     PISSN: 14712466     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2466-4-6     Document Type: Article

References (37)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference onARDS Definitions, Mechanisms, Relevant Outcomes, and Clinical Trial Coordination. Am J Respir Crit Care Med 1994, 149:818-824.
2. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM: Adult respiratory distress syndrome risk with common predispositions. Ann Intern Med 1983, 98:593-597.
3. Rinaldo JE., Christman JW: Mechanisms and Mediators of the adult respiratory distress syndrome. Clin Chest Med 1990, 11: 21-629.
4. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982, 144:124-128.
5. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996, 154:602-611.
6. Bellingan GJ: The pathogenesis of ALI/ARDS. Thorax 2002, 57:540-6.
7. Tomashefski JF Jr: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000, 21: 35-466.
8. Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 1999, 160:961-967.
9. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164:1896-1903.
10. Tamura DY, Moore EE, Partrick DA, Johnson JL, Zallen G, Silliman CC: IL-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998, 76:91-94.
11. Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med 1998, 26:1194-1199.
12. Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest 1999, 116:2S-8S.
13. Mulligan SM, Jones ML, Vaporciyan AA, Maureen CH, Ward PA: Protective effects of IL-4 and IL-10 against immune complexinduced lung injury. J Immunol 1993, 151:5666-5674.
14. Van Laetherm JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Devieve J: Multisystem production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998, 43: 08-413.
15. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997, 111:1306-21.
16. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-14.
17. Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996, 9: 858-67.
18. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: Prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 1995, 274:639-644.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-29.
21. Baldwin DR, Wise R, Andrews JM, Honeybourne D: Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax 1991, 46:658-662.
22. Grassi J, Frobert Y, Pradelles P, Chercuitte F, Gruaz D, Dayer JM, Poubelle PE: Production of monoclonal antibodies against IL-1a and IL-1b: development of the two-enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Meth 1989, 123:193-210.
23. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-77.
24. Mitchell RS: Lung cytokines and ARDS. Chest 1999, 116:2S-8S.
25. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995, 107: 062-1073.
26. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991, 91:23-29.
27. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992, 146: 27-432.
28. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996, 125: 91-196.
29. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at risk patients. Am J Respir Crit Care Med 1997, 155:1469-1473.
30. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI: Airway inflammation. Ann Intern Med 1995, 123: 88-304.
31. Agouridakis P, Kyriakou D, Alexandrakis MG, Prekates A, Perisinakis K, Karkavitsas N, Bouros D: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 2002, 23(3(1)):25.
32. Agouridakis P, Kyriakou D, Alexandrakis MG, Persinakis K, Karkavitsas N, Bouros D: Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest 2002, 32:862-867.
33. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Chest 1995, 108:1303-1314.
34. Kiehl MG, Ostermann H, Thomas M, Muller T, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acite respiratory distress syndrome. Crit Care Med 1998, 26:1194-1198.
35. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of IL-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996, 125:191-196.
36. Armstrong L, Millar AB: Relative production of tumour necrosis factor alpha and interleukin in adult respiratory distress syndrome. Thorax 1997, 52:442-446.
37. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164:1896-1903.